Gene products can provide valuable information for risk assessment by identifying individuals or populations at higher risk of adverse effects from toxic exposures. Biomarkers derived from gene products can help in the early detection of toxic effects, improving the accuracy of risk assessments and enabling the implementation of preventive measures.
